Essential Thrombocythemia Following Immune Thrombocytopenia With JAK2 V617F Mutation: A Case Report

Essential Thrombocythemia Following Immune Thrombocytopenia With JAK2 V617F Mutation: A Case Report

Immune Thrombocytopenia (ITP) is an autoimmune bleeding disorder. Tyrosine Kinase JAK2 (JAK2 V617F) mutation occurs in nearly 60% of Essential Thrombocythemia (ET) patients. Both diseases produce impaired platelet. We describe a case with ET following ITP. So far, only 3 reports described ET followi...

Full description

Bibliographic Details
Main Authors: Mehrdad Payandeh, Mehrnoush Aeinfar, Kimiya Dadashizadeh, saba yari
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2021-11-01
Series:Case Reports in Clinical Practice
Subjects:
Jak2 mutation
Essential thrombocythemia
Immune thrombocytopenia
Online Access:https://crcp.tums.ac.ir/index.php/crcp/article/view/400

Similar Items

Similar Items